Topas Therapeutics GmbH

Falkenried 88, Haus A
20251 Hamburg GERMANY

+49 40 302089010


Topas is utilizing its cutting-edge nanoparticle technology platform to develop a pipeline of novel therapies to treat autoimmune and antigen-driven diseases. Our platform is advancing to the clinic in two antigen-specific indications.

©2023 Topas Therapeutics. All rights reserved.